+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia



The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia



Administration and Policy in Mental Health 34(3): 307-314



While some studies show a significant advantage in adherence rates with use of atypical versus typical antipsychotic medication, others show no advantage or mixed results (Jones et al. (2006). Archives of General Psychiatry, 63, 1079-1087; Rosenheck, (2006). Archives of General Psychiatry, 63, 1074-1076). This study examined treatment outcomes and costs associated with adherence rates by antipsychotic medication class for adult Medicaid beneficiaries in Florida diagnosed with schizophrenia. Outcomes examined include arrests, involuntary commitments, and physical and behavioral healthcare costs. Study findings demonstrate that medication adherence for persons with schizophrenia may be as important to treatment costs and benefits as the class of medication used.

(PDF emailed within 0-6 h: $19.90)

Accession: 050713533

Download citation: RISBibTeXText

PMID: 17211716

DOI: 10.1007/s10488-006-0108-5


Related references

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161(4): 692-699, 2004

Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations. Psychiatric Services 66(2): 127-133, 2015

Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. American Journal of Managed Care 15(7): 437-445, 2010

Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Affairs 22(4): 220-229, 2003

Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate. Pharmacoeconomics - Open: -, 2018

Evaluation of specialized medication packaging combined with medication therapy management: adherence, outcomes, and costs among Medicaid patients. Medical Care 50(6): 485-493, 2012

Schizophrenia and antipsychotic medication--better adherence, better outcomes?. Schizophrenia Research 151(1-3): 296-297, 2014

A Medicaid and commercial insured claims-based study to estimate improved antipsychotic medication adherence among patients with schizophrenia. Journal of Behavioral Health Services & Research 40(2): 222-233, 2014

The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. Plos One 7(4): E36080-E36080, 2012

Relationship between costs and symptoms in schizophrenia patients treated with antipsychotic medication: a review. Journal of Clinical Psychiatry 65(6): 756-765, 2004

Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program. Journal of Child and Adolescent Psychopharmacology 21(1): 79-84, 2011

Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research 176(2-3): 109-113, 2010

Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004. Psychiatric Services 58(7): 1007-1010, 2007

The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study. Annals of General Psychiatry 8(): 7-7, 2009

Medication continuity among Medicaid beneficiaries with schizophrenia and bipolar disorder. Psychiatric Services 64(9): 878-885, 2014